These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31461776)

  • 1. [French comment on article Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study].
    Endoscopy; 2019 Sep; 51(9):904. PubMed ID: 31461776
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study.
    Jang SI; Lee KT; Choi JS; Jeong S; Lee DH; Kim YT; Lee SH; Yu JS; Lee DK
    Endoscopy; 2019 Sep; 51(9):843-851. PubMed ID: 30414164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract.
    Jang SI; Jeong S; Lee DH; Na K; Yang S; Lee DK
    Gut Liver; 2019 Apr; 13(4):471-478. PubMed ID: 30970427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study.
    Song TJ; Lee SS; Yun SC; Park DH; Seo DW; Lee SK; Kim MH
    Gastrointest Endosc; 2011 Apr; 73(4):727-33. PubMed ID: 21288514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue.
    Jeong D; Lee DH; Lee DK; Na K
    J Biomater Appl; 2015 Mar; 29(8):1133-44. PubMed ID: 25252589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety evaluation of paclitaxel-loaded metal stents in patients with malignant biliary obstructions.
    Yuan T; Zhu Y; Wang X; Cui W; Cao J
    Eur J Surg Oncol; 2019 May; 45(5):816-819. PubMed ID: 30389299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
    Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
    Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-expandable metal stents in malignant biliary obstruction.
    Jaganmohan S; Lee JH
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):105-14. PubMed ID: 22149586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. French comment on article: Evaluation of a newly modified nonflared fully covered metal stent, 12 mm in diameter, for intraductal placement in patients with malignant biliary strictures: a feasibility study.
    Endoscopy; 2016 Jul; 48(7):694. PubMed ID: 27351534
    [No Abstract]   [Full Text] [Related]  

  • 15. Metal versus plastic stents for malignant biliary obstruction: an update meta-analysis.
    Hong WD; Chen XW; Wu WZ; Zhu QH; Chen XR
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):496-500. PubMed ID: 23333231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial.
    Wagner HJ; Knyrim K; Vakil N; Klose KJ
    Endoscopy; 1993 Mar; 25(3):213-8. PubMed ID: 7686100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized study for efficacy of an uncovered double bare metal stent compared to a single bare metal stent in malignant biliary obstruction.
    Lee HJ; Chung MJ; Park JY; Park SW; Nam CM; Song SY; Bang S
    Surg Endosc; 2017 Aug; 31(8):3159-3167. PubMed ID: 27864713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction.
    Moss AC; Morris E; Leyden J; MacMathuna P
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1119-24. PubMed ID: 17998839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study.
    Pleva L; Kukla P; Zapletalova J; Hlinomaz O
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E416-E424. PubMed ID: 30019843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.